Mereo BioPharma Group Statistics
Total Valuation
MREO has a market cap or net worth of $51.08 million. The enterprise value is $10.29 million.
Important Dates
The next estimated earnings date is Tuesday, May 12, 2026, before market open.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MREO has 159.62 million shares outstanding. The number of shares has increased by 7.77% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 159.62M |
| Shares Change (YoY) | +7.77% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 1.21% |
| Owned by Institutions (%) | 16.09% |
| Float | 114.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 102.15 |
| Forward PS | n/a |
| PB Ratio | 1.24 |
| P/TBV Ratio | 1.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 20.57 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.46, with a Debt / Equity ratio of 0.00.
| Current Ratio | 10.46 |
| Quick Ratio | 9.99 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -151.20 |
Financial Efficiency
Return on equity (ROE) is -82.21% and return on invested capital (ROIC) is -44.41%.
| Return on Equity (ROE) | -82.21% |
| Return on Assets (ROA) | -39.41% |
| Return on Invested Capital (ROIC) | -44.41% |
| Return on Capital Employed (ROCE) | -92.65% |
| Weighted Average Cost of Capital (WACC) | 6.69% |
| Revenue Per Employee | $12,821 |
| Profits Per Employee | -$1.07M |
| Employee Count | 39 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.25% in the last 52 weeks. The beta is 0.38, so MREO's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -85.25% |
| 50-Day Moving Average | 0.40 |
| 200-Day Moving Average | 1.46 |
| Relative Strength Index (RSI) | 34.06 |
| Average Volume (20 Days) | 1,374,549 |
Short Selling Information
The latest short interest is 11.26 million, so 9.95% of the outstanding shares have been sold short.
| Short Interest | 11.26M |
| Short Previous Month | 13.76M |
| Short % of Shares Out | 9.95% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.57 |
Income Statement
In the last 12 months, MREO had revenue of $500,000 and -$41.88 million in losses. Loss per share was -$0.26.
| Revenue | 500,000 |
| Gross Profit | 367,000 |
| Operating Income | -38.56M |
| Pretax Income | -41.88M |
| Net Income | -41.88M |
| EBITDA | -37.94M |
| EBIT | -38.56M |
| Loss Per Share | -$0.26 |
Full Income StatementBalance Sheet
The company has $40.99 million in cash and $202,000 in debt, with a net cash position of $40.79 million or $0.26 per share.
| Cash & Cash Equivalents | 40.99M |
| Total Debt | 202,000 |
| Net Cash | 40.79M |
| Net Cash Per Share | $0.26 |
| Equity (Book Value) | 40.92M |
| Book Value Per Share | 0.26 |
| Working Capital | 40.72M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$30.97 million and capital expenditures -$20,000, giving a free cash flow of -$30.99 million.
| Operating Cash Flow | -30.97M |
| Capital Expenditures | -20,000 |
| Depreciation & Amortization | 622,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -30.99M |
| FCF Per Share | -$0.19 |
Full Cash Flow StatementMargins
| Gross Margin | 73.40% |
| Operating Margin | -7,711.40% |
| Pretax Margin | -8,375.60% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MREO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.77% |
| Shareholder Yield | n/a |
| Earnings Yield | -81.99% |
| FCF Yield | -60.68% |
Analyst Forecast
The average price target for MREO is $1.50, which is 368.75% higher than the current price. The consensus rating is "Buy".
| Price Target | $1.50 |
| Price Target Difference | 368.75% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 191.48% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MREO has an Altman Z-Score of 25.39 and a Piotroski F-Score of 2.
| Altman Z-Score | 25.39 |
| Piotroski F-Score | 2 |
